You're contacting media contact of this press release

Title: CoreAge Rx Sees 40 Percent Surge in GLP-1 Inquiries as Spring Weight Loss Season Begins

United States, 19th Mar 2026 — As warmer weather approaches and individuals across the United States begin preparing for summer, CoreAge Rx, a leading telehealth pharmacy, reports a significant 40% increase in inquiries related to GLP-1 weight loss treatments. This seasonal surge highlights a growing trend of individuals seeking effective, medically guided solutions to achieve their health and fitness goals ahead of summer.Spring has long been associated with renewed focus on health and wellness, but in recent years, the demand for clinically supported weight loss options has accelerated. CoreAge Rx attributes this increase in interest to a combination of greater public awareness around GLP-1 medications and a shift toward more personalized, convenient healthcare solutions.“Every year, we see a noticeable uptick in weight loss inquiries as spring begins, but this year’s 40% increase is particularly significant,” said Ella Jones, spokesperson for CoreAge Rx. “Patients are not just looking for quick fixes—they want safe, sustainable, and medically supervised options that fit into their lifestyles.”GLP-1 receptor agonists have gained widespread attention for their ability to support weight loss by regulating appetite and improving metabolic function. As more individuals become informed about these treatments, telehealth providers like CoreAge Rx are playing a critical role in making access easier and more discreet.CoreAge Rx offers a streamlined, patient-first approach to weight management. Through its secure telehealth platform, patients can consult with licensed healthcare professionals, receive personalized treatment plans, and have medications delivered directly to their homes. This model eliminates the need for in-person visits, providing both convenience and pri...

This press release is issued by King Newswire